FDA Focuses on Fosamax

Agency conducts a safety review of osteoporosis drug's possible side effects.
3:00 | 03/11/10

Coming up in the next {{countdown}} {{countdownlbl}}

Coming up next:

{{nextVideo.title}}

{{nextVideo.description}}

Skip to this video now

Now Playing:

{{currentVideo.title}}

Comments
Related Extras
Related Videos
Video Transcript
Transcript for FDA Focuses on Fosamax

This transcript has been automatically generated and may not be 100% accurate.

{"id":10071166,"title":"FDA Focuses on Fosamax","duration":"3:00","description":"Agency conducts a safety review of osteoporosis drug's possible side effects.","url":"/GMA/OnCall/video/fda-focuses-fosamax-10071166","section":"GMA","mediaType":"default"}